Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US

Aballea, S., Chancellor, J.V.M., Raikou, M. et al. (4 more authors) (2007) Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US. Cancer, 109 (6). pp. 1082-1089. ISSN 0008-543X

Abstract

Metadata

Authors/Creators:
  • Aballea, S.
  • Chancellor, J.V.M.
  • Raikou, M.
  • Drummond, M.F.
  • Weinstein, M.C.
  • Jourdan, S.
  • Bridgewater, J.
Copyright, Publisher and Additional Information: Open access copy available from the journal web site.
Keywords: oxaliplatin, colon cancer, cost effectiveness, survival analysis
Institution: The University of York
Academic Units: The University of York > Centre for Health Economics (York)
Depositing User: Open Access From Journal
Date Deposited: 23 Dec 2008 13:42
Last Modified: 23 Dec 2008 13:42
Published Version: http://dx.doi.org/10.1002/cncr.22512
Status: Published
Publisher: Wiley-Blackwell
Refereed: Yes
Identification Number: https://doi.org/10.1002/cncr.22512

Share / Export

Statistics